What's on Practical Law?
The FTC Finds that Authorized Generic Drugs Yield Procompetitive Benefits
Practical Law Article 4-508-6181 (Approx. 2 pages)
The FTC Finds that Authorized Generic Drugs Yield Procompetitive Benefits
by Dechert LLP
This Law Firm Publication by Dechert LLP discusses an FTC study on the competitive impact of authorized generics, providing strong support for the conclusion that entry by authorized generics is procompetitive because it lowers prescription drug prices without deterring generic entry.
End of Document
Resource ID 4-508-6181© 2024 Thomson Reuters. All rights reserved.